Diagnostics Partnering Terms and Agreements
11-Apr-2012 | News-Press Release
The Diagnostics Partnering Terms and Agreements report provides comprehensive  understanding and unprecedented access to the diagnostic partnering agreements  entered into by the worlds leading companies.
  * Comprehensive directory of diagnostic deals since 2007
  * Diagnostic contract documents
  * Diagnostic agreement terms
  * Diagnostic agreement structure
  * Top diagnostic deals by value
  * Most active diagnostic dealmakers
  http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/diagnostics-partnering-terms-and-agreements.html
  
  Description
  The Diagnostics Partnering Terms and Agreements report provides  comprehensive understanding and unprecedented access to the diagnostic  partnering agreements entered into by the worlds leading healthcare companies. Business Research
  
  The report provides a detailed understanding and analysis of how and why  companies enter diagnostic partnering deals. The majority of deals are  development stage whereby the licensee obtains a right or an option right to  license the licensors diagnostic technology or product candidates. These deals  tend to be multicomponent, starting with collaborative R&D, and  commercialization of outcomes.
  
  Understanding the flexibility of a prospective partner’s negotiated deals terms  provides critical insight into the negotiation process in terms of what you can  expect to achieve during the negotiation of terms. Whilst many smaller companies  will be seeking details of the payments clauses, the devil is in the detail in  terms of how payments are triggered – contract documents provide this insight  where press releases and databases do not.
  
  This report contains a comprehensive listing of all diagnostics partnering deals  announced since January 2007, including financial terms where available,  including over 3,000 links to online deal records of actual diagnostics  partnering deals as disclosed by the deal parties. In addition, where available,  records include contract documents as submitted to the Securities Exchange  Commission by companies and their partners.
  
  The initial chapters of this report provide an orientation of diagnostics  dealmaking and business activities. Chapter 1 provides an introduction to the  report, whilst chapter 2 provides an overview of the trends in diagnostics  dealmaking since 2007, including details of average headline, upfront, milestone  and royalty terms.
  
  Chapter 3 provides a review of the leading diagnostics deals since 2007. Deals  are listed by headline value, signed by bigpharma, most active bigpharma, and  most active of all biopharma companies. Where the deal has an agreement contract  published at the SEC a link provides online access to the contract.
  
  Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies  with a brief summary followed by a comprehensive listing of diagnostics deals,  as well as contract documents available in the public domain. Where available,  each deal title links via Weblink to an online version of the actual contract  document, providing easy access to each contract document on demand.
  
  Chapter 5 provides a comprehensive and detailed review of diagnostics partnering  deals signed and announced since January 2007, where a contract document is  available in the public domain. The chapter is organized by stage of development  at signing, deal type (collaborative R&D, co-promotion, licensing etc), and  specific therapy focus. Each deal title links via Weblink to an online version  of the deal record and where available, the contract document, providing easy  access to each contract document on demand.
  
  The report also includes numerous tables and figures that illustrate the trends  and activities in diagnostics partnering and dealmaking since 2007.
  
  In conclusion, this report provides everything a prospective dealmaker needs to  know about partnering in the research, development and commercialization of  diagnostics technologies and products.
  
  Report scope
  Diagnostics Partnering Terms and Agreements is intended to provide the  reader with an in-depth understanding of the diagnostic trends and structure of  deals entered into by leading companies worldwide.
  
  For more information kindly visit : 
  Diagnostics Partnering Terms and Agreements
  
  Or
  
  Bharat Book Bureau
  Tel: +91 22 27810772 / 27810773
  Fax: + 91 22 27812290
  Email: info@bharatbook.com
  Website: www.bharatbook.com
  Follow us on twitter:  http://twitter.com/#!/Sandhya3B
This release was submitted by a Newsbox user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Research on Global and China Epoxy Resin Industry Chain Report
 - The Geothermal Energy Market 2012-2022
 - Adhesives and Sealants: Global Markets
 - Dermatological Drugs: World Market Prospects 2012-2022
 - The Electric and Range Extended Electric Light-Vehicle Report
 - India Urban & Industrial Waste to Energy Market
 - Understanding Russia's Regional Health Markets
 - 2012 Deep Research Report on China Wind Bearing Industry
 - Top 1000 Advertising Agents (European)
 - HNWI Asset Allocation in Switzerland to 2016
 
		


